Rigel Pharmaceuticals (RIGL) Non-cash Items (2012 - 2025)

Rigel Pharmaceuticals has reported Non-cash Items for 14 years, with the latest figure at $3.2 million in Q3 2025.

• For the quarter ending Q3 2025, Non-cash Items rose 28.0% year-over-year to $3.2 million; the trailing twelve-month figure through Sep 2025 stood at $3.2 million (up 28.0% YoY), and the FY2024 full-year result was $10.6 million, down 56.52% from the prior year.
• Non-cash Items for Q3 2025 stood at $3.2 million, down from $20.5 million in the prior quarter.
• The five-year high for Non-cash Items was $24.4 million in Q4 2023, with the low at $1.6 million in Q4 2022.
• Average Non-cash Items over 5 years is $8.3 million, with a median of $5.3 million recorded in 2023.
• Year-over-year, Non-cash Items soared 1418.93% in 2023 and sank 78.4% in 2025.
• Tracing RIGL's Non-cash Items over 5 years: stood at $6.8 million in 2021, then plunged by 76.44% to $1.6 million in 2022, then soared by 1418.93% to $24.4 million in 2023, then slumped by 56.52% to $10.6 million in 2024, then tumbled by 69.81% to $3.2 million in 2025.
• The last three Non-cash Items figures came in at $3.2 million (Q3 2025), $20.5 million (Q2 2025), and $3.5 million (Q1 2025), per Business Quant data.

Peer Comparison